Evidence map›Paper›PMID 35812163›Full record

ArticleNeurology. Genetics2022

FUS-P525L Juvenile Amyotrophic Lateral Sclerosis and Intellectual Disability: Evidence for Association and Oligogenic Inheritance.

Orly Goldstein, Talya Inbar, Merav Kedmi, Mali Gana-Weisz, Beatrice Abramovich, Avi Orr-Urtreger, Vivian E Drory

Open access · goldAbstract read
In one paragraph

Article in Neurology. Genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Dysregulation of mitochondrial bioenergetics, RNA processing, and cellular stress responses in FUS-ALS: a multi-dataset transcriptomic perspective.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Orly GoldsteinThe Genomic Research Laboratory for Neurodegeneration (O.G., M.K., M.G.-W., A.O.-U.), Neurological Institute, Tel Aviv Sourasky Medical Center; Sackler Faculty of Medicine (T.I., A.O.-U., V.E.D.), Tel Aviv University; and Neuromuscular Diseases Unit (B.A., V.E.D.), Department of Neurology, Tel Aviv Sourasky Medical Center, Israel.
Talya InbarThe Genomic Research Laboratory for Neurodegeneration (O.G., M.K., M.G.-W., A.O.-U.), Neurological Institute, Tel Aviv Sourasky Medical Center; Sackler Faculty of Medicine (T.I., A.O.-U., V.E.D.), Tel Aviv University; and Neuromuscular Diseases Unit (B.A., V.E.D.), Department of Neurology, Tel Aviv Sourasky Medical Center, Israel.
Merav KedmiThe Genomic Research Laboratory for Neurodegeneration (O.G., M.K., M.G.-W., A.O.-U.), Neurological Institute, Tel Aviv Sourasky Medical Center; Sackler Faculty of Medicine (T.I., A.O.-U., V.E.D.), Tel Aviv University; and Neuromuscular Diseases Unit (B.A., V.E.D.), Department of Neurology, Tel Aviv Sourasky Medical Center, Israel.
Mali Gana-WeiszThe Genomic Research Laboratory for Neurodegeneration (O.G., M.K., M.G.-W., A.O.-U.), Neurological Institute, Tel Aviv Sourasky Medical Center; Sackler Faculty of Medicine (T.I., A.O.-U., V.E.D.), Tel Aviv University; and Neuromuscular Diseases Unit (B.A., V.E.D.), Department of Neurology, Tel Aviv Sourasky Medical Center, Israel.
Beatrice AbramovichThe Genomic Research Laboratory for Neurodegeneration (O.G., M.K., M.G.-W., A.O.-U.), Neurological Institute, Tel Aviv Sourasky Medical Center; Sackler Faculty of Medicine (T.I., A.O.-U., V.E.D.), Tel Aviv University; and Neuromuscular Diseases Unit (B.A., V.E.D.), Department of Neurology, Tel Aviv Sourasky Medical Center, Israel.
Avi Orr-UrtregerThe Genomic Research Laboratory for Neurodegeneration (O.G., M.K., M.G.-W., A.O.-U.), Neurological Institute, Tel Aviv Sourasky Medical Center; Sackler Faculty of Medicine (T.I., A.O.-U., V.E.D.), Tel Aviv University; and Neuromuscular Diseases Unit (B.A., V.E.D.), Department of Neurology, Tel Aviv Sourasky Medical Center, Israel.
Vivian E DroryThe Genomic Research Laboratory for Neurodegeneration (O.G., M.K., M.G.-W., A.O.-U.), Neurological Institute, Tel Aviv Sourasky Medical Center; Sackler Faculty of Medicine (T.I., A.O.-U., V.E.D.), Tel Aviv University; and Neuromuscular Diseases Unit (B.A., V.E.D.), Department of Neurology, Tel Aviv Sourasky Medical Center, Israel.
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Amyotrophic lateral sclerosis (ALS) is characterized by upper and lower motor neuron degeneration, with juvenile ALS (jALS) defined as disease with age at onset (AAO) before 25 years. We aimed to identify the genetic basis of 2 unrelated patients with jALS with very rapid deterioration and early age intellectual disability (ID) and to assess association of genetic findings with both phenotypes in a large cohort of patients with ALS and controls, and in the literature. Methods: Exome sequencing was performed in 2 unrelated probands and their parents. Trio analyses included de novo, rare homozygosity, and compound heterozygosity analyses. A TaqMan genotyping assay was used to genotype ALS cohorts. A systematic literature review was conducted and additional information from authors obtained to assess prevalence of fused in sarcoma ( Results: A de novo mutation Discussion:

Identifiers

PMID35812163
PMCPMC9258982
OpenAlexW4285040563

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.